ClinicalTrials HQ

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Recruiting · NCT07023835 · Registry updated 2026-09-01
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral SclerosisNutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorderRecruitingPhase 22026-09-01NCT07023835

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Zydus Therapeutics Inc.6

49 results · Page 1 of 2

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Zydus 100QuébecCanada1
Zydus 101TorontoCanada1
Zydus 110LeuvenBelgium1
Zydus 120ParisFrance1
Zydus 121ToursFrance1
Zydus 122LimogesFrance1
Zydus 123MontpellierFrance1
Zydus 124Clermont-FerrandFrance1
Zydus 125NiceFrance1
Zydus 130DresdenGermany1
Zydus 131LübeckGermany1
Zydus 132RostockGermany1
Zydus 133HanoverGermany1
Zydus 134JenaGermany1
Zydus 135UlmGermany1
Zydus 140DublinIreland1
Zydus 150BresciaItaly1
Zydus 151ModenaItaly1
Zydus 152NaplesItaly1
Zydus 153MilanItaly1
Zydus 154GenovaItaly1
Zydus 160UtrechtNetherlands1
Zydus 170KrakowPoland1
Zydus 171WarsawPoland1
Zydus 180AlicanteSpain1